0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia

Elliott Rees, PhD1; Kimberley Kendall, MBBCh1; Antonio F. Pardiñas, PhD1; Sophie E. Legge, PhD1; Andrew Pocklington, PhD1; Valentina Escott-Price, PhD1; James H. MacCabe, PhD, MRCPsych2; David A. Collier, PhD3,4; Peter Holmans, PhD1; Michael C. O’Donovan, PhD, FRCPsych1; Michael J. Owen, PhD, FRCPsych1,5; James T. R. Walters, MRCPsych, PhD1; George Kirov, PhD, MRCPsych1
[+] Author Affiliations
1Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, Wales
2Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, England
3SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England
4Discovery Neuroscience Research, Eli Lilly and Company Ltd, Lilly Research Laboratories, Surrey, England
5Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, Wales
JAMA Psychiatry. 2016;73(9):963-969. doi:10.1001/jamapsychiatry.2016.1831.
Text Size: A A A
Published online

Importance  At least 11 rare copy number variants (CNVs) have been shown to be major risk factors for schizophrenia (SZ). These CNVs also increase the risk for other neurodevelopmental disorders, such as intellectual disability. It is possible that additional intellectual disability–associated CNVs increase the risk for SZ but have not yet been implicated in SZ because of previous studies being underpowered.

Objective  To examine whether additional CNVs implicated in intellectual disability represent novel SZ risk loci.

Design, Setting, and Participants  We used single-nucleotide polymorphism (SNP) array data to evaluate a set of 51 CNVs implicated in intellectual disability (excluding the known SZ loci) in a large data set of patients with SZ and healthy persons serving as controls recruited in a variety of settings. We analyzed a new sample of 6934 individuals with SZ and 8751 controls and combined those data with previously published large data sets for a total of 20 403 cases of SZ and 26 628 controls.

Main Outcomes and Measures  Burden analysis of CNVs implicated in intellectual disability (excluding known SZ CNVs) for association with SZ. Association of individual intellectual disability CNV loci with SZ.

Results  Of data on the 20 403 cases (6151 [30.15%] female) and 26 628 controls (14 252 [53.52%] female), 51 intellectual disability CNVs were analyzed. Collectively, intellectual disability CNVs were significantly enriched for SZ (P = 1.0 × 10−6; odds ratio [OR], 1.9 [95% CI, 1.46-2.49]). Of the 51 CNVs tested, 19 (37%) were more common in SZ cases; only 4 (8%) were more common in controls (no observations were made for the remaining 28 [55%] loci). One novel locus, deletion at 16p12.1, was significantly associated with SZ after correction for multiple testing (rate in SZ, 33 [0.16%]; rate in controls, 12 [0.05%]; corrected P = .017; OR, 3.3; 95% CI, 1.61-7.05), and 2 loci reached nominal levels of significance (deletions at 2q11.2: 6 [0.03%] vs 1 [0.004%]; OR, 9.3; 95% CI, 1.03-447.76; corrected P > .99; and duplications at 10q11.21q11.23: 5 [0.2%] vs 0 [0.03%]; OR, infinity; 95% CI, 1.26-infinity; corrected P = .71). Our new data set also provided independent support for the 11 SZ risk loci previously reported to be associated with the disorder and for the protective effect of 22q11.2 duplication.

Conclusions and Relevance  A large proportion of CNV loci implicated in intellectual disability are risk factors for SZ, but the available sample size precludes statistical confirmation for additional individual loci.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Place holder to copy figure label and caption
Figure.
Analysis of Intellectual Disability Copy Number Variants (CNVs) Power Calculation

Power calculations for CNV loci under a dominant model are based on 20 403 cases and 26 628 controls, an α level of .05, and the relative risks for schizophrenia (SZ) and general population frequencies reported in eTable 2 in the Supplement. The solid line indicates 80% power given a sample size of 20 403 cases and 26 628 controls with an α level of .05. The dashed line indicates 80% power given a sample size of 100 000 cases and 100 000 controls with an α level of .05. We excluded loci that were not observed in a patient with SZ or a control. del indicates deletion; dup, duplication.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

510 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();